Abstract
BackgroundAlthough dose tapering of tumour necrosis factor (TNF)-blockers in ankylosing spondylitis (AS) showed a comparable clinical efficacy with favourable safety and cost in some studies, there has been no investigation...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
